Building a Biotech’s First Digital Function. 5x Return on Digital Investment in 18 Months.
How I built a global biotech’s first digital function, delivering a 5x return on digital investment in 18 months.

The Challenge
- Buy-in: Getting teams that ran their own digital projects to back one shared function.
- Cost: Reducing agency spend and paying once for shared assets.
- Access: Reaching physicians, investigators, and patients after the pandemic stopped in-person contact.
- Enrollment: Finding rare-disease patients who lived far from study sites.
The Solution
Earning Support in a Science-First Culture
The company’s culture was built on its scientific legacy, and rightly so. When the pandemic made digital a priority, I had to find sponsors. The CFO, one of our main sponsors, asked what digital would mean for the business and how it would improve financial returns. Clinical operations asked why they couldn’t build their own websites or hire an agency directly.
Both questions came from leaders who wanted to understand what digital could do for their work. So, I built the company’s first Digital Center of Excellence to manage digital as a shared service. It set digital policy and approval rights. The Center also brought digital implementation in-house, cutting costs and speeding up delivery.

.webp)


A Single End-to-End Content Supply Chain
A shared service only pays off if content moves faster through it. I led the move of the company’s digital properties onto one secure Microsoft Azure platform, which cut hosting costs and centralized security and GxP controls. On it, I set up a single content supply chain. Teams built reusable modules in Adobe Experience Manager and ran them through medical, legal, and regulatory review in Veeva Vault PromoMats. Approved modules then went out across websites, email, and Veeva CRM.
Every market-facing team drew from this supply chain, and medical content stayed separate from promotion. When the pandemic pushed every interaction online, I trained field teams on the new channels so they could stay in touch with physicians and patient communities.
Finding Patients Beyond Trial Sites
Rare-disease patients are few, and many live far from a study site. So I built a clinical trial recruitment platform. It combined disease education and advocacy partnerships with a clear way for clinicians to refer patients. It grew to 9 million subscribers, including patients, healthcare professionals, caregivers, and advocates.
Clinical and advocacy teams ran recruitment content through the same review process, so no study needed its own system. The company could reuse the platform across Phase II–IV studies and each new rare-disease program.
Digital finally had one owner, and the clinical teams that once wanted their own websites were running recruitment through it.
Explore more projects

How I built a global biotech’s first digital function, delivering a 5x return on digital investment in 18 months.
.png)
.png)
Scaled a trauma therapy practice through recovery-centered branding and AI agents that streamlined administrative workflows.



Let’s shape what comes next.
Whether you are bringing a healthcare innovation to market, accelerating commercial growth, or putting AI to work, let’s discuss what it takes to move your business forward.


.png)

